Showing results (91-100 of 451) with videos related to

Sort By:
Pageof 46
Immunology Today|October 8, 2014
Allostimulation-induced tumor cytotoxic cells: from mouse to manG Parmiani, M Sensi, G Fossati
International Journal of Cancer|October 15, 1980
Expression of alien minor histocompatibility antigens distinct from tumor-specific transplantation antigen on a murine fibrosarcomaG Parmiani, M Colombo, D Ballinari
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Analysis of the cellular immune response to and adoptive immunotherapy of a BALB/c lymphoma that cross-reacts with normal DBA/2 cellsM Sensi, L Grazioli, G Parmiani
The Journal of Experimental Medicine|January 1, 1986
Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clonesA Anichini, G Fossati, G Parmiani
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 1, 1992
Beta 1-integrins on melanoma clones regulate the interaction with autologous cytolytic T-cell clonesA Anichini, R Mortarini, G Parmiani
Immunology Today|October 8, 2014
Clonal analysis of the cytolytic T-cell response to human tumorsA Anichini, G Fossati, G Parmiani
Journal of the National Cancer Institute|March 7, 1990
Cellular immune response against autologous human malignant melanoma: are in vitro studies providing a framework for a more effective immunotherapy?G Parmiani, A Anichini, G Fossati
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Influence of the donors' clinical status on in vitro and in vivo tumor-cytotoxic activation of interleukin-2-exposed lymphocytes and their circulation in different organsM Rodolfo, C Salvi, G Parmiani
The Journal of Experimental Medicine|January 1, 1995
Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytesC Castelli, W J Storkus, M J Maeurer, et al.
Targeted Oncology|September 19, 2014
Dose-finding/phase II trial: bevacizumab, immunotherapy, and chemotherapy (BIC) in metastatic renal cell cancer (mRCC). Antitumor effects and variations of circulating T regulatory cells (Treg)M Donini, S Buti, S Lazzarelli, et al.
Pageof 46